Expectations trend
FY2027 · fiscal year ending 2027-09-30 · fmp
NASDAQInformation TechnologyCommunication EquipmentSnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for CLFD yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Annual revenue between $160M and $170M for fiscal 2026 | Clearfield aims for annual revenue of $160M to $170M in fiscal 2026. | Broken | Annual revenue falls below $160 million in FY26 | Revenue: $43.864M FY2026-Q3; GAAP. Published target: >= $160 million. Annual target cannot be compared with a quarterly or TTM observation. Aug 6, 202643,864,000 USD · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-09-30 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 10, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earningsObserved price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a higher-risk growth recovery story, not yet a proven durable compounder. The long-term thesis is in a watch state: quarterly results improved, but guidance was lowered and the overall signal recently shifted to mixed.
CLFD is rated expensive, with a valuation premium versus peers and an expectations gap that points to demanding assumptions. The priced-in fragility assessment is low because expensive valuation is not paired with the full combination of weak fundamentals and market turbulence.
Near term, results show improvement: revenue rose from $34.4 million in the first quarter of fiscal 2026 to $43.9 million in the second, and operating income moved from a loss to income. But fiscal 2026 sales guidance was cut, the company remains loss-making on the overall earnings-quality measure, and a recent CEO transition adds uncertainty; the supplied evidence gives limited detail on its implications.
Over the next few quarters, a return to stronger guidance and continued core-business recovery would support the thesis, while another setback would weaken it. The first significant $22 million hyperscale data center order, with shipments expected in early fiscal 2027, is important evidence of progress, but broader expansion remains unproven. Rate cuts and stabilization among technology peers are possible sector tailwinds, not company-specific proof.
The 1-to-3-year view is a mixed recovery story: quarterly improvement and a meaningful data center order are balanced by reduced annual guidance, elevated risk, and an expensive valuation. The thesis hinges on sustained core recovery and broader data center growth. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| It extended its credit line to support financial stability. |
| Intact |
| Line of credit maturity not extended beyond July 2026 |
Maturity extended to Nov 2026 vs Jul 2026 target July 2026 amendment extended credit line maturity from July 24, 2026 to November 21, 2026. Nov 5, 2026Last status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
EPS between $0.48 and $0.62 for fiscal 2026 | Clearfield aims for annual revenue of $160M to $170M in fiscal 2026. | Broken | EPS remains below $0.48 in FY26 | Diluted EPS: $0.22 per share FY2026-Q3; GAAP. Published target: >= $0.48. Annual target cannot be compared with a quarterly or TTM observation. Aug 6, 20260.22 USD/share · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$1.45 → $0.89 · observed estimates
$0.20B → $0.19B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $1.45 | $200,366,670 | 2 / 3 |
| 2026-07-25 | $1.45 | $200,366,670 | 2 / 3 |
| 2026-07-26 | $1.45 | $200,366,670 | 2 / 3 |
| 2026-07-27 | $1.45 | $200,366,670 | 2 / 3 |
| 2026-07-28 | $1.45 | $200,366,670 | 2 / 3 |
| 2026-07-29 | $1.45 | $200,366,670 | 2 / 3 |
| 2026-07-30 | $1.45 | $200,366,670 | 2 / 3 |
| 2026-07-31 | $1.22 | $200,050,000 | 2 / 3 |
| 2026-08-01 | $1.22 | $200,050,000 | 2 / 3 |
| 2026-08-02 | $1.45 | $200,366,670 | 2 / 3 |
| 2026-08-03 | $1.45 | $200,366,670 | 2 / 3 |
| 2026-08-04 | $1.45 | $200,366,670 | 2 / 3 |
| 2026-08-05 | $1.22 | $200,050,000 | 2 / 3 |
| 2026-08-06 | $1.22 | $200,050,000 | 2 / 3 |
| 2026-08-07 | $1.07 | $190,168,950 | 2 / 3 |
| 2026-08-08 | $1.45 | $189,875,000 | 2 / 4 |
| 2026-08-09 | $1.07 | $190,168,950 | 2 / 3 |
| 2026-08-10 | $1.07 | $190,168,950 | 2 / 3 |
| 2026-08-11 | $1.07 | $190,168,950 | 2 / 3 |
| 2026-08-12 | $1.07 | $190,168,950 | 2 / 3 |
| 2026-08-13 | $1.16 | $187,075,000 | 1 / 4 |
| 2026-08-14 | $1.07 | $190,168,950 | 2 / 3 |
| 2026-08-15 | $1.07 | $190,168,950 | 2 / 3 |
| 2026-08-16 | $1.07 | $190,168,950 | 2 / 3 |
| 2026-08-17 | $1.07 | $190,168,950 | 2 / 3 |
| 2026-08-18 | $1.07 | $190,168,950 | 2 / 3 |
| 2026-08-19 | $1.07 | $190,168,950 | 2 / 3 |
| 2026-08-20 | $0.89 | $187,075,000 | 2 / 3 |
| 2026-08-21 | $0.89 | $187,075,000 | 2 / 3 |
| 2026-08-22 | $0.89 | $187,075,000 | 2 / 3 |
| 2026-08-23 | $0.89 | $187,075,000 | 2 / 3 |
| 2026-08-24 | $0.89 | $187,075,000 | 2 / 3 |
| 2026-08-25 | $0.89 | $187,075,000 | 2 / 3 |
| 2026-08-26 | $0.89 | $187,075,000 | 2 / 3 |
| 2026-08-27 | $0.89 | $187,075,000 | 2 / 3 |
| 2026-08-28 | $0.89 | $187,075,000 | 2 / 3 |
| 2026-08-29 | $0.89 | $187,075,000 | 2 / 3 |
| 2026-08-30 | $0.89 | $187,075,000 | 2 / 3 |
| 2026-08-31 | $0.89 | $187,075,000 | 2 / 3 |
| 2026-09-01 | $0.89 | $187,075,000 | 2 / 3 |
| 2026-09-02 | $0.89 | $187,075,000 | 2 / 3 |
| 2026-09-03 | $0.89 | $187,075,000 | 2 / 3 |
| 2026-09-04 | $0.89 | $187,075,000 | 2 / 3 |
| 2026-09-05 | $0.89 | $187,075,000 | 2 / 3 |
| 2026-09-06 | $0.89 | $187,075,000 | 2 / 3 |
| 2026-09-07 | $0.89 | $187,075,000 | 2 / 3 |
| 2026-09-08 | $0.89 | $187,075,000 | 2 / 3 |
| 2026-09-09 | $0.89 | $187,075,000 | 2 / 3 |
| 2026-09-10 | $0.89 | $187,075,000 | 2 / 3 |
| 2026-09-11 | $0.89 | $187,075,000 | 2 / 3 |
| 2026-09-12 | $0.89 | $187,075,000 | 2 / 3 |
| 2026-09-13 | $0.89 | $187,075,000 | 2 / 3 |
| 2026-09-14 | $0.89 | $187,075,000 | 2 / 3 |
| 2026-09-15 | $0.89 | $187,075,000 | 2 / 3 |
| 2026-09-16 | $0.89 | $187,075,000 | 2 / 3 |
| 2026-09-17 | $0.89 | $187,075,000 | 2 / 3 |
| 2026-09-18 | $0.89 | $187,075,000 | 2 / 3 |
| 2026-09-19 | $0.89 | $187,075,000 | 2 / 3 |
| 2026-09-20 | $0.89 | $187,075,000 | 2 / 3 |
| 2026-09-21 | $0.89 | $187,075,000 | 2 / 3 |
| 2026-09-22 | $0.89 | $187,075,000 | 2 / 3 |
| 2026-09-23 | $0.89 | $187,075,000 | 2 / 3 |
| 2026-09-24 | $0.89 | $187,075,000 | 2 / 3 |
| 2026-09-25 | $0.89 | $187,075,000 | 2 / 3 |
| 2026-09-26 | $0.89 | $187,075,000 | 2 / 3 |
| 2026-09-27 | $0.89 | $187,075,000 | 2 / 3 |
| 2026-09-28 | $0.89 | $187,075,000 | 2 / 3 |
| 2026-09-29 | $0.89 | $187,075,000 | 2 / 3 |
| 2026-09-30 | $0.89 | $187,075,000 | 2 / 3 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 4 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 7–Nov 5 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
2 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.